Poor prognosis of HIV-associated tuberculous meningitis regardless of the timing of antiretroviral therapy

scientific article published on June 2011

Poor prognosis of HIV-associated tuberculous meningitis regardless of the timing of antiretroviral therapy is …
instance of (P31):
editorialQ871232
scholarly articleQ13442814

External links are
P356DOI10.1093/CID/CIR239
P932PMC publication ID3097370
P698PubMed publication ID21596681
P5875ResearchGate publication ID51150531

P50authorStephen LawnQ28151824
Robin WoodQ60590121
P2860cites workClinical and microbiological features of HIV-associated tuberculous meningitis in Vietnamese adultsQ28472258
Rapid molecular detection of tuberculosis and rifampin resistanceQ29617127
Antiretroviral therapy for control of the HIV-associated tuberculosis epidemic in resource-limited settingsQ33920318
Dexamethasone for the treatment of tuberculous meningitis in adolescents and adultsQ33982474
Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort studyQ34125176
Epidemiology of HIV-associated tuberculosisQ34519940
Timing of initiation of antiretroviral drugs during tuberculosis therapyQ34790184
Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of AmericaQ34974892
Timing of initiation of antiretroviral therapy in human immunodeficiency virus (HIV)--associated tuberculous meningitisQ35121804
Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretroviralsQ36141214
Strategies to reduce early morbidity and mortality in adults receiving antiretroviral therapy in resource-limited settingsQ37168581
Changing mortality risk associated with CD4 cell response to antiretroviral therapy in South AfricaQ37179716
Early antiretroviral therapy reduces AIDS progression/death in individuals with acute opportunistic infections: a multicenter randomized strategy trialQ37189075
Optimum time to start antiretroviral therapy during HIV-associated opportunistic infectionsQ37240766
Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan AfricaQ37265947
Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa.Q37357376
Immune reconstitution disease of the central nervous system.Q37447778
The HIV-associated tuberculosis epidemic--when will we act?Q37757652
Early versus delayed initiation of antiretroviral therapy for concurrent HIV infection and cryptococcal meningitis in sub-saharan AfricaQ38374183
Effect of antituberculosis drug resistance on response to treatment and outcome in adults with tuberculous meningitisQ39523752
Antiretrovirals and isoniazid preventive therapy in the prevention of HIV-associated tuberculosis in settings with limited health-care resourcesQ42977188
Short-term risk of AIDS or death in people infected with HIV-1 before antiretroviral therapy in South Africa: a longitudinal studyQ46350540
Survival rate and risk factors of mortality among HIV/tuberculosis-coinfected patients with and without antiretroviral therapyQ80051726
Optimum time to initiate antiretroviral therapy in patients with HIV-associated tuberculosis: there may be more than one right answerQ81382088
Effect of simultaneous use of highly active antiretroviral therapy on survival of HIV patients with tuberculosisQ83161994
P433issue11
P407language of work or nameEnglishQ1860
P921main subjectmeningitisQ48143
tuberculous meningitisQ3854687
P304page(s)1384-1387
P577publication date2011-06-01
P1433published inClinical Infectious DiseasesQ5133764
P1476titlePoor prognosis of HIV-associated tuberculous meningitis regardless of the timing of antiretroviral therapy
P478volume52

Reverse relations

cites work (P2860)
Q38113260Drug-resistant tuberculous meningitis
Q34212799Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of the
Q37965693Interventions to reduce mortality in sub-Saharan Africa among HIV-infected adults not yet on antiretroviral therapy
Q38414352Opportunistic infections and immune reconstitution inflammatory syndrome in HIV-1-infected adults in the combined antiretroviral therapy era: a comprehensive review
Q36058313Paradoxical reaction in tuberculous meningitis: presentation, predictors and impact on prognosis
Q37285167Reducing deaths from tuberculosis in antiretroviral treatment programmes in sub-Saharan Africa

Search more.